MiMedx Group MDXG Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by MiMedx Group in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about MiMedx Group's accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MiMedx Group's accounts receivable, credit loss expense (reversal)?
- MiMedx Group (MDXG) reported accounts receivable, credit loss expense (reversal) of $1.46M in Q1 2026.
- How has MiMedx Group's accounts receivable, credit loss expense (reversal) changed year-over-year?
- MiMedx Group's accounts receivable, credit loss expense (reversal) increased by 97.3% year-over-year, from $742K to $1.46M.
- What is the long-term trend for MiMedx Group's accounts receivable, credit loss expense (reversal)?
- Over 3 years (2022 to 2025), MiMedx Group's accounts receivable, credit loss expense (reversal) has grown at a 35.9% compound annual growth rate (CAGR), from $2.6M to $6.52M.